Helix Bridge Life Sciences

Where Science Meets Commercial Reality in Africa & Middle East.

We partner with biopharma companies to translate scientific innovation into commercial and patient impact — across Africa and the Middle East. Senior practitioners. No juniors on your account.

Science-Led, Practitioner-Delivered
Senior Expertise. Every Engagement.
Africa Market Depth. 22+ Years.
Global Standards. Local Execution.

Who We Are

Helix Bridge Life Sciences is a boutique consulting firm built on two decades of hands-on experience in African and Middle Eastern pharma markets. We are not a generalist firm that occasionally touches life sciences — this is all we do, and we do it at the level your business requires.

Our model is simple: senior practitioners only, embedded deeply in your challenge, accountable for outcomes. We do not believe one-size-fits-all solutions exist in healthcare. Every engagement is designed around your specific context, goals, and stage of maturity.

What We Do

From market entry strategy to commercial transformation, from market access navigation to launch execution — our five service families cover the full arc of a pharma company's commercial journey in Africa and the Middle East.

Our Approach

We start by listening — because the real challenge is rarely the one described in the first conversation. Our three-phase method moves from deep discovery to bespoke design to hands-on delivery, with senior practitioners present at every stage.

What makes this different: we do not hand over a slide deck and disappear. We stay close to the work until results are visible.

The People Behind Helix Bridge

Helix Bridge was founded on a belief that the best consulting comes from people who have actually done the work — not advised on it from a distance. Our team brings together decades of commercial leadership, medical affairs, market access, and operational experience from within the African pharma industry itself.

Our extended expert network allows us to bring the right specialists to every engagement, at the scale that fits your project — without the overhead of a global firm.

Insights & Perspectives

Our thinking on the forces shaping pharma in Africa and the Middle East — written by practitioners, for practitioners.

The Africa Go-to-Market Model: Why Copy-Paste from Emerging Markets Fails — and What to Build Instead

Pharma companies entering African markets frequently rely on commercial models borrowed from other emerging markets — Latin America, South-East Asia, Eastern Europe — and are surprised when they underperform. Sub-Saharan and North African markets require purpose-built GTM architectures that account for channel fragmentation, regulatory heterogeneity, and informal distribution dynamics that simply do not exist elsewhere.

Read More

From SFE to P&L: Building a Commercial Excellence Engine That Actually Moves the Numbers

Commercial excellence in African pharma markets is not about installing a CRM or redesigning territories in isolation — it is about connecting salesforce effectiveness, marketing precision, and pricing discipline into an integrated commercial system that delivers measurable P&L improvement. Here is what that connection looks like in practice, and where most organisations break the chain.

Read More

Geographical Expansion in Africa: Why On-the-Ground Due Diligence Is the Non-Negotiable First Step

Every year, pharma companies sign distribution agreements in African markets on the strength of desk research, broker recommendations, or regional reputation alone — and most of them pay for it. Genuine market intelligence in Africa requires field visits, health authority conversations, and distributor reference checks that cannot be replicated from a laptop. The companies that expand successfully are the ones that understand this before they commit.

Read More

Ready to build the bridge?

Tell us where you are. We'll help you get to where you need to be.

Let's Connect